CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) — Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period. Results for Quarter Ended December 31, 2025 Consolidated operating results:Revenue was $639.3 million, essentially flat with the fourth quarter of 2024 GAAP Diluted Earnings-per-Share (EPS) of $5.48, a decrease of 9.0% Adjusted Diluted EPS of $6.42, a decrease of 6.0%VITAS segment operating results:Net Patient Revenue of $418.8 million, an increase of 1.9% Average Daily Census (ADC) of 22,462, an increase of 1.3% Admissions...

HOUSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced its operating and financial results for the fourth quarter and full year of 2025. Whitestone creates neighborhood center communities in its high-quality open-air shopping centers that it acquires, owns, manages, develops, and redevelops primarily in some of the largest, fastest-growing, high-household-income markets in the Sunbelt. For the three months ended December 31, 2025 and 2024, Net income attributable to common shareholders per diluted share was $0.43 and $0.33, respectively. For the full year 2025 and 2024, Net income attributable to common shareholders per diluted share was $0.95 and $0.72, respectively. “We are pleased to report strong fourth quarter and full year operating and financial results. We delivered...

SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) — California Water Service Group (Group or Company, NYSE: CWT), a leading publicly traded water utility serving California, Hawaii, New Mexico, Washington, and Texas, today reported solid Q4 and year-end 2025 results and provided an update on the Proposed Decision in its 2024 California General Rate Case (2024 CA GRC). Fourth Quarter and Year-End 2025 Results in Line with Expectations; Impacted by Wet Q4 Weather Q4 Financial Results Q4 2025 net income decreased $8.2 million, or 42%, to $11.5 million, or $0.19 per diluted share, compared to net income of $19.7 million, or $0.33 per diluted share in Q4 2024. Q4 2025 revenue decreased $2.2 million, or less than 1.0%, to $220.0 million, compared to revenue of $222.2 million in Q4 2024.Rate changes and changes in the Monterey-Style...

THORNTON, Colo., Feb. 25, 2026 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR” or the “Company”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced today its fourth-quarter and full year 2025 financial results. Fourth Quarter 2025 HighlightsQuarterly revenues of $973.5 million Record quarterly net income of $36.5 million, or $2.33 per diluted share Record quarterly EBITDA of $64.2 millionFull Year 2025 HighlightsRecord full-year revenues of $3.66 billion Record full-year net income of $118.4 million, or $7.53 per diluted share Record full-year EBITDA of $232.7 million Record backlog of $2.82 billionManagement CommentsRick Swartz, MYR’s President and CEO, said, “We closed...

Full Year 2025 Total Revenues of $589.0 Million, Representing 19.8% Year-Over-Year Growth and Marking Another Year of Record Total Revenues Q4 2025 Total Revenues of $152.6 Million, Fueled by 18.3% FIRDAPSE® (amifampridine) Growth and 67.5% Growth of AGAMREE® (vamorolone), Reflecting Continued Adoption Full Year 2026 Total Revenues Expected to be Between $615 Million and $645 Million, Reflecting Confidence in Strength and Durability of FIRDAPSE and AGAMREE Franchises Promoted Product Revenue, Net Expected to Grow by 20% or More in 2026 Conference Call and Webcast to be Held on February 26, 2026, at 8:30 AM ET CORAL GABLES, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today reported financial results for fourth quarter and full year 2025 and provided full year 2026...

FY2025 in line with guidance Operational turnaround and transformation on track FY 2025 results, including MeTS:€4.5B Group revenue1, -2.4% organically vs 2024 (guidance of low single digit percentage decline) €841M adjusted EBITDA1, 18.7% adj EBITDA margin (guidance at €830m to €855m) €(9)M free cash flow12 (guidance at €-30M to €0M+) with €(49)M in H2 2025 Net result at €(5,157)M Group Share including €(4,647)M impairments of goodwill Normalised net results at €175MExcluding MeTS (under IFRS53) revenues, adjusted EBITDA and free cash flow respectively amount to €4.0B, €737M and €(26)M Turnaround and transformation on trackImproved churn in all geographies and improved order intake and pipeline in financial services in Q4 2025 Transformation initiatives operationalized with benefits in Q4 2025 and clear milestones for 2026 Pruning...

FULL-YEAR RESULTS FOR 2025DERISKED, DELEVERAGED BALANCE SHEETCONSOLIDATION OF LEADERSHIP POSITIONFURTHER IMPROVEMENT IN OPERATING PROFITABILITY AND LEVERAGE RATIO IN 2026Nexity ready to rebound: Operational momentum and financial discipline evident in results for 2025Derisked, deleveraged balance sheet:Net financial debt at �278m ahead of the increase in the shareholding in Angelotti, representing a �52m reduction in debt (vs net financial debt of �330m in 2024); Group net financial debt of �328m at year-end 2025, equating to Group debt being halved in 2 years Free cash flow positive in 2025, with �107m in operating free cash flow Opportunistic decisions, with accounting impacts on net profit, reflected in the generation of free cash flow over the full yearCurrent operating profit/(loss) (COP)1 equating to net profit of �25m...

Amsterdam, 25 February 2026 (Regulated Information) — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) reports full year adjusted EBITDA of $235 million in 2025, a 40% increase compared to the 2024 adjusted EBITDA of $168 million, driven primarily by our Antimony and Engineering businesses. We ended the year with a strong balance sheet highlighted by our $484 million of total liquidity as of December 31, 2025. Dr. Heinz Schimmelbusch, Chairman of the Management Board and CEO, said, “In 2025, we achieved the third highest adjusted EBITDA in the Company’s history despite weakness in lithium and vanadium. This flexible response to a changing market environment highlights the quality and the breadth of our critical materials and technologies portfolio. Governments are pushing for onshoring of critical materials supply,...

Ayvens’ 2025 Financial statements are available on Ayvens’ corporate website (www.ayvens.com) in the Investors section under “Financial Results”. The financial information presented for the financial year ending 31 December 2025 was approved by the Board of Directors on 5 February 2026 under the chairmanship of Pierre Palmieri and has been prepared in accordance with IFRS as adopted in the European Union and applicable at that date. The audit procedures carried out on the consolidated annual financial statements are in progress. About AyvensAyvens is a leading global sustainable mobility player committed to making life flow better. We’ve been improving mobility for decades, providing full-service leasing, flexible subscription services, fleet management and multi-mobility solutions to large international corporates,...

Press ReleaseParis, February 25, 2026          74Software: Guidance Increased as Operational Discipline Drives Significant Margin ExpansionFY 2025 revenue reached €707.2m, up +3.8% organically, with both Axway (€337.9m, +4.6%) and SBS (€371.2m, +3.0%) contributing to the Group’s performance. Annual recurring revenue expanded further, with ARR growth of 11.8% at Axway and 8.9% at SBS, strengthening predictability and supporting the durability of the business model. Full-year operating profitability improved significantly, with margin on operating activities increasing by 160 bps to 15.2%, representing €107.3m; the SBS integration and profitability improvement plan remained firmly on track. Unlevered FCF per share reached an all-time high of €2.75, reflecting the operating improvements and sound working capital management in 2025. AI-driven...